Skip to main content

Advertisement

Table 1 Patient data

From: Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer

Number of patients 55
Age (years)
 Mean (SD) 68.3 (6.9)
 Range 48–83
Gleason score
 3 + 3 9
 3 + 4 16
 4 + 3 12
 4 + 4 6
 5 + 3 1
 4 + 5 9
 5 + 4 1
 Unknown 1
PSA at diagnosis (ng/mL)
 Mean (SD) 11.2 (12.5)
 Range 4.0–88.0
Post-treatment PSA nadir (ng/mL)
 Mean (SD) 0.5 (1.1)
 Range 0–5.1
Post-treatment PSA (ng/mL)
 Mean (SD) 7.9 (12.9)
 Range 0.2–84.0
PSA doubling time (months)
 Mean (SD) 7.1 (6.6)
Post-treatment PSA grouping (n)
 0–1 ng/mL 8 (14.5%)
 1–2 ng/mL 10 (18.2%)
 > 2 ng/mL 37 (67.3%)
Treatment (n)
 Prostatectomy 16 (29.1%)
 Radiation 18 (32.7%)
 Prostatectomy and radiation 21 (38.2%)